logoTry Persana

Nuntius Therapeutics - Company Overview, Founder, CEO, Funding & Investment Details

Complete information about Nuntius Therapeutics including founder details, CEO information, total funding raised, headquarters location, team size, and recent investment rounds.

Nuntius Therapeutics company logo

Genetic medicines to cure patients with life-threatening diseases

Nuntius Therapeutics develops transformative mRNA therapies using proprietary delivery technology, machine learning, and superior nucleic acid engineering.

HeadquartersLondon, United Kingdom
Team size11-50
Founded2021

What is Nuntius Therapeutics? - Company Overview & Details

Nuntius Therapeutics is Nuntius Therapeutics develops transformative mRNA therapies using proprietary delivery technology, machine learning, and superior nucleic acid engineering. Founded in 2021, the company is headquartered in London, United Kingdom.

Who Founded Nuntius Therapeutics?

Nuntius Therapeutics was founded by Benita Nagel, Albert Kwok.

Who are the Key Executives at Nuntius Therapeutics? - Leadership Team

Nuntius Therapeutics is led by experienced executives in key positions:

Chief Executive Officer (CEO) of Nuntius Therapeutics

Benita NagelCEO

Chief Technology Officer (CTO) of Nuntius Therapeutics

Albert KwokCTO

About Benita Nagel - CEO of Nuntius Therapeutics

Benita Nagel serves as the Chief Executive Officer of Nuntius Therapeutics, leading the company's strategic vision and operations. Connect with them on LinkedIn for professional insights.

Nuntius Therapeutics Company Details & Key Information

Where is Nuntius Therapeutics located?

Nuntius Therapeutics is headquartered in London, United Kingdom.

How many employees does Nuntius Therapeutics have?

Nuntius Therapeutics has 11-50 employees.

When was Nuntius Therapeutics founded?

Nuntius Therapeutics was founded in 2021.

Nuntius Therapeutics Official Website

How much funding has Nuntius Therapeutics raised?

Nuntius Therapeutics has raised $125,000 across 2 funding rounds. The most recent funding was completed on 2021-04-22.

Funding Overview

Nuntius Therapeutics raised $125,000 in a pre-seed funding round led by Y Combinator.

$125,000
Total Funding Raised
2
Funding Rounds
2021-04-22
Latest Round

Nuntius Therapeutics Funding History

Pre seed
2021-04-22
$125,000
Series unknown
2021-04-22

Who are the key investors in Nuntius Therapeutics?

Nuntius Therapeutics is backed by 1 key investors including Y Combinator. These investors focus on Biotechnology, Startups sectors.

Nuntius Therapeutics Investor Overview

1
Key Investors
2
Focus Areas
1
Notable Investments

Complete List of Nuntius Therapeutics Investors

Y Combinator

A startup accelerator that helps launch early-stage companies.

Investment Focus
Biotechnology
Startups
Notable Portfolio Companies
Nuntius Therapeutics

What sectors do Nuntius Therapeutics investors focus on?

The investors backing Nuntius Therapeutics primarily focus on Biotechnology, Startups sectors.

Biotechnology
Startups

Featured Investor: Y Combinator

Y Combinator

A startup accelerator that helps launch early-stage companies.

Notable Investments: Nuntius Therapeutics

What are Nuntius Therapeutics's future plans?

Nuntius Therapeutics Nuntius aims to expand its pipeline of mRNA therapeutics for various diseases, while continuously improving its delivery technology.

Nuntius Therapeutics Strategic Outlook

Strategic Focus
Defined
2
Key Challenges
2
Growth Opportunities

What challenges does Nuntius Therapeutics face?

Nuntius Therapeutics has identified 2 key challenges that need to be addressed for continued growth and success.

Key Challenges for Nuntius Therapeutics

1

Delivery of mRNA therapies to specific tissues

2

Maintaining confidentiality in collaborations

What opportunities does Nuntius Therapeutics have?

Nuntius Therapeutics has identified 2 key opportunities for growth and market expansion.

Growth Opportunities for Nuntius Therapeutics

1

Partnerships with pharmaceutical companies

2

Advancements in machine learning for drug development

Nuntius Therapeutics Strategic Position Summary

Key Focus Areas

Nuntius Therapeutics is addressing 2 strategic challenges to strengthen its market position.

Growth Potential

The company has identified 2 key opportunities for expansion and growth.

What are the latest news about Nuntius Therapeutics?

Nuntius Therapeutics has 2 recent news updates covering key business developments and market activities.

Nuntius Therapeutics News Overview

2
Recent Articles
Active
Media Coverage
2024-08-16
Latest Update

What is Nuntius Therapeutics in the news for?

Nuntius Therapeutics is currently featured in news for Nuntiustx partnered with Taiho Pharmaceutical Co., Ltd on Aug 16th '24. and other significant business developments.

Recent News Articles About Nuntius Therapeutics

Article 1
2024-08-16

Nuntiustx partnered with Taiho Pharmaceutical Co., Ltd on Aug 16th '24.

Nuntius Therapeutics has entered a partnership with Taiho Pharmaceutical to develop mRNA-based cancer immunotherapies.

genengnews.com
Read News
Article 2
2024-08-16

Nuntiustx is developing next-generation messenger ribonucleic acid cancer immunotherapies.

The partnership will leverage Nuntius' nanocarrier technologies for targeting cell types beyond the liver.

pharmaceutical-technology.com
Read News

Nuntius Therapeutics FAQ - Frequently Asked Questions About Founder, CEO, Funding & Company Details

Find answers to the most common questions about Nuntius Therapeutics including information about founders, CEO, funding history, investors, headquarters location, and company details. 19 frequently asked questions covering key information about the company.

Nuntius Therapeutics Questions & Answers - Company Information

Q1

What is Nuntius Therapeutics?

Nuntius Therapeutics develops transformative mRNA therapies using proprietary delivery technology, machine learning, and superior nucleic acid engineering.

Q2

Who founded Nuntius Therapeutics?

Nuntius Therapeutics was founded by Benita Nagel, Albert Kwok.

Q3

Who is the CEO of Nuntius Therapeutics?

The CEO of Nuntius Therapeutics is Benita Nagel. You can find more information about them on their LinkedIn profile.

Q4

How much funding has Nuntius Therapeutics raised?

Nuntius Therapeutics has raised a total of $$125,000 across 2 funding rounds. The most recent funding was completed on 2021-04-22.

Q5

Who are the investors in Nuntius Therapeutics?

Nuntius Therapeutics's key investors include Y Combinator.

Q6

Where is Nuntius Therapeutics headquartered?

Nuntius Therapeutics is headquartered in London, United Kingdom.

Q7

When was Nuntius Therapeutics founded?

Nuntius Therapeutics was founded in 2021.

Q8

How many employees does Nuntius Therapeutics have?

Nuntius Therapeutics has 11-50 employees.

Q9

What is Nuntius Therapeutics's official website?

You can visit Nuntius Therapeutics's official website at http://www.nuntiustx.com.

Q10

What was Nuntius Therapeutics's latest funding round?

Nuntius Therapeutics's latest funding round was a Pre seed round of $$125,000 completed on 2021-04-22.

Q11

Who is founder?

Benita Nagel

Q12

Who is cto?

Albert Kwok

Q13

What does the company do?

Nuntius Therapeutics develops transformative mRNA therapies using proprietary delivery technology, machine learning, and superior nucleic acid engineering.

Q14

How much funding?

$125,000

Q15

Latest funding date?

2021-04-22

Q16

Who are the investors?

Y Combinator

Q17

What are the challenges?

Delivery of mRNA therapies to specific tissues Maintaining confidentiality in collaborations

Q18

What are the opportunities?

Partnerships with pharmaceutical companies Advancements in machine learning for drug development

Q19

Latest news?

Nuntius Therapeutics has entered a partnership with Taiho Pharmaceutical to develop mRNA-based cancer immunotherapies. The partnership will leverage Nuntius' nanocarrier technologies for targeting cell types beyond the liver.

More Information About Nuntius Therapeutics

For additional details about Nuntius Therapeutics, including the latest news, funding updates, and company developments, explore our comprehensive company database. Find information about startup funding, company valuations, executive leadership, and business intelligence data.